Apollomics Inc Cl A
(APLM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLM | AZN | AMGN | GILD | VRTX |
| Company | Apollomics Inc Cl A | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 17.76 | 93.03 | 340.81 | 139.08 | 471.18 |
| High | 17.76 | 93.35 | 345.50 | 141.73 | 475.67 |
| Low | 17.76 | 92.62 | 338.07 | 138.65 | 468.00 |
| Latest | 17.76 | 93.13 | 340.38 | 140.84 | 472.46 |
| Change | -0.16 | +0.54 | -2.56 | +1.29 | -3.22 |
| % Change | -0.89% | +0.58% | -0.75% | +0.92% | -0.68% |
| Volume | 2,236 | 2,332,076 | 664,729 | 2,026,253 | 237,865 |
| 20-Day Average Volume | 17,107 | 9,279,987 | 2,652,855 | 7,372,050 | 1,484,270 |
| Previous Close | 17.92 | 92.59 | 342.94 | 139.55 | 475.68 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 19.76 | 93.42 | 335.46 | 128.06 | 462.37 |
| 20-Day Raw Stochastic | 4.42% | 55.35% | 65.07% | 96.46% | 73.05% |
| 20-Day Relative Strength | 47.76 | 52.58 | 55.53 | 68.56 | 57.16 |
| Weighted Alpha | -16.89 | +34.93 | +22.72 | +48.63 | +7.28 |
| Today's Opinion | 72% Buy | 88% Buy | 100% Buy | 100% Buy | 88% Buy |
| Previous Opinion | 72% Buy | 88% Buy | 100% Buy | 100% Buy | 88% Buy |
| Last Month's Opinion | 88% Buy | 100% Buy | 96% Buy | 80% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.33% since 01/23/26 | +0.24% since 01/23/26 | -1.08% since 01/23/26 | +3.62% since 01/23/26 | +0.71% since 01/23/26 |
| Low | 17.52 on 01/29/26 | 92.57 on 01/29/26 | 338.35 on 01/30/26 | 133.69 on 01/26/26 | 468.00 on 01/30/26 |
| High | 20.50 on 01/27/26 | 96.18 on 01/27/26 | 353.25 on 01/27/26 | 141.73 on 01/30/26 | 485.00 on 01/27/26 |
| 1-Month | |||||
| %Chg | -14.12% since 12/30/25 | +0.72% since 12/30/25 | +3.75% since 12/30/25 | +14.34% since 12/30/25 | +3.97% since 12/30/25 |
| Low | 17.52 on 01/05/26 | 89.04 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 22.97 on 01/09/26 | 96.51 on 01/07/26 | 353.25 on 01/27/26 | 141.73 on 01/30/26 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +52.97% since 10/30/25 | +13.16% since 10/30/25 | +16.78% since 10/30/25 | +18.92% since 10/30/25 | +12.35% since 10/30/25 |
| Low | 11.30 on 11/05/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 26.95 on 11/17/25 | 96.51 on 01/07/26 | 353.25 on 01/27/26 | 141.73 on 01/30/26 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +208.87% since 07/30/25 | +21.65% since 07/30/25 | +13.15% since 07/30/25 | +22.73% since 07/30/25 | +0.55% since 07/30/25 |
| Low | 3.66 on 08/29/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 362.50 on 08/11/25 |
| High | 42.12 on 10/15/25 | 96.51 on 01/07/26 | 353.25 on 01/27/26 | 141.73 on 01/30/26 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 19,771 | 287,197,120 | 184,666,688 | 173,136,896 | 120,689,048 |
| Shares Outstanding, K | 1,103 | 3,101,816 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 1,490,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -53,860,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | N/A | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | N/A | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.79 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 04/02/26 | 02/10/26 | 02/03/26 | 02/10/26 | 02/12/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.40 | 15.65 | 17.06 | 31.22 |